RothGAMensahGAJohnsonCO, et al.Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol2020; 76: 2982–3021.
2.
NkomoVTGardinJMSkeltonTN, et al.Burden of valvular heart diseases: a population-based study. Lancet2006; 368: 1005–1011.
3.
BadhwarVRankinJSHeX, et al.The Society of Thoracic Surgeons mitral repair/replacement composite score: a report of the Society of Thoracic Surgeons Quality Measurement Task Force. Ann Thorac Surg2016; 101: 2265–2271.
4.
GammieJSShengSGriffithBP, et al.Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Database. Ann Thorac Surg2009; 87: 1431–1439.
5.
MohtyDOrszulakTASchaffHV, et al.Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation2001; 104: I1–I7.
6.
BeuteTJGoehlerMParkerJ, et al.Long-term outcomes of mosaic versus perimount mitral replacements: 17-year follow-up of 940 implants. Ann Thorac Surg2020; 110: 508–515.
7.
AnselmiAAymamiMTomasiJ, et al.Durability of mitral valve replacement with a 3rd generation bioprosthesis. Ann Thorac Surg. Epub ahead of print23 April 2021. DOI: 10.1016/j.athoracsur.2021.03.097.
8.
DavidTEArmstrongSMcCrindleBW, et al.Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation2013; 127: 1485–1492.
9.
LazamSVanoverscheldeJLTribouilloyC, et al.Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter, international registry. Circulation2017; 135: 410–422.
10.
ZhugeRHouXQiX, et al.Analysis of the clinical features of and treatment options for mitral regurgitation in elderly inpatients. J Geriatr Cardiol2018; 15: 428–433.
11.
KwedarKMcNeelyCZajariasA, et al.Outcomes of early mitral valve reoperation in the Medicare population. Ann Thorac Surg2017; 104: 1516–1521.
12.
KilicAAckerMAGleasonTG, et al.Clinical outcomes of mitral valve reoperations in the United States: an analysis of the Society of Thoracic Surgeons National Database. Ann Thorac Surg2019; 107: 754–759.
13.
CheungAWebbJGWongDR, et al.Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg2009; 87: e18–e20.
14.
De WegerAEweSHDelgadoV, et al.First-in-man implantation of a trans-catheter aortic valve in a mitral annuloplasty ring: novel treatment modality for failed mitral valve repair. Eur J Cardiothorac Surg2011; 39: 1054–1056.
BouletiCFassaAAHimbertD, et al.Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty. JACC Cardiovasc Interv2015; 8: 83–91.
17.
YeJCheungAYamashitaM, et al.Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves an 8-year single-center experience. JACC Cardiovasc Interv2015; 8: 1735–1744.
18.
SeiffertMConradiLBaldusS, et al.Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses. JACC Cardiovasc Interv2012; 5: 341–349.
19.
UrenaMBrochetELecomteM, et al.Clinical and haemodynamic outcomes of balloon-expandable transcatheter mitral valve implantation: a 7-year experience. Eur Heart J2018; 39: 2679–2689.
20.
YoonSHWhisenantBKBleizifferS, et al.Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings. J Am Coll Cardiol2017; 70: 1121–1131.
21.
YoonSHWhisenantBKBleizifferS, et al.Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J2019; 40: 441–451.
22.
SimonatoMWhisenantBRibeiroHB, et al.Transcatheter mitral valve replacement after surgical repair or replacement: comprehensive midterm evaluation of valve-in-valve and valve-in-ring implantation from the VIVID registry. Circulation2021; 143: 104–116.
23.
WhisenantBKapadiaSREleidMF, et al.One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve. JAMA Cardiol2020; 5: 1245–1252.
24.
GuerreroMVemulapalliSXiangQ, et al.Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States: data from the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv2020; 13: e008425.
25.
GuerreroMPursnaniANarangA, et al.Prospective evaluation of transseptal TMVR for failed surgical bioprostheses: MITRAL trial valve-in-valve arm 1-year outcomes. JACC Cardiovasc Interv2021; 14: 859–872.
26.
GuerreroMWangDDPursnaniA, et al.Prospective evaluation of TMVR for failed surgical annuloplasty rings: MITRAL trial valve-in-ring arm 1-year outcomes. JACC Cardiovasc Interv2021; 14: 846–858.
27.
SenguptaAYazdchiFAlexisSL, et al.Reoperative mitral surgery versus transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc2021; 10: e019854.
28.
JavadikasgariHChemtobRAGillinovAM, et al.Outcomes of mitral valve re-replacement for bioprosthetic structural valve deterioration. J Thorac Cardiovasc Surg. Epub ahead of print25 August 2020. DOI: 10.1016/j.jtcvs.2020.08.067.
29.
ZahidSUllahWKhanMU, et al.Meta-analysis comparing valve in valve transcatheter mitral valve replacement versus redo surgical mitral valve replacement for degenerating bioprosthetic valves. Am J Cardiol2021; 149: 155–156.
30.
LittleSHBapatVBlankeP, et al.Imaging guidance for transcatheter mitral valve intervention on prosthetic valves, rings, and annular calcification. JACC Cardiovasc Imaging2021; 14: 22–40.
KhanJMBabaliarosVCGreenbaumAB, et al.Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement. J Am Coll Cardiol2019; 73: 2521–2534.
33.
YoonSHBleizifferSLatibA, et al.Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement. JACC Cardiovasc Interv2019; 12: 182–193.
34.
BlankePNaoumCDvirD, et al.Predicting LVOT obstruction in transcatheter mitral valve implantation: concept of the neo-LVOT. JACC Cardiovasc Imaging2017; 10: 482–485.
35.
WangDDEngMHGreenbaumAB, et al.Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR). Catheter Cardiovasc Interv2018; 92: 379–387.
36.
WangDDGuerreroMEngMH, et al.Alcohol septal ablation to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: first-in-man study. JACC Cardiovasc Interv2019; 12: 1268–1279.
37.
GuerreroMWangDDO’NeillW. Percutaneous alcohol septal ablation to acutely reduce left ventricular outflow tract obstruction induced by transcatheter mitral valve replacement. Catheter Cardiovasc Interv2016; 88: E191–E197.
38.
BabaliarosVCGreenbaumABKhanJM, et al.Intentional percutaneous laceration of the anterior mitral leaflet to prevent outflow obstruction during transcatheter mitral valve replacement: first-in-human experience. JACC Cardiovasc Interv2017; 10: 798–809.
39.
KhanJMRogersTBabaliarosVC, et al.Predicting left ventricular outflow tract obstruction despite anterior mitral leaflet resection: the “skirt NeoLVOT.”JACC Cardiovasc Imaging2018; 11: 1356–1359.
40.
LiskoJCGreenbaumABKhanJM, et al.Antegrade intentional laceration of the anterior mitral leaflet to prevent left ventricular outflow tract obstruction: a simplified technique from bench to bedside. Circ Cardiovasc Interv2020; 13: e008903.
41.
LiskoJCBabaliarosVCKhanJM, et al.Tip-to-base LAMPOON for transcatheter mitral valve replacement with a protected mitral annulus. JACC Cardiovasc Interv2021; 14: 541–550.
42.
HelmyTHuiDSSmartS, et al.Balloon assisted translocation of the mitral anterior leaflet to prevent left ventricular outflow obstruction (BATMAN): a novel technique for patients undergoing transcatheter mitral valve replacement. Catheter Cardiovasc Interv2020; 95: 840–848.
43.
RibeiroHBDahouAUrenaM, et al.Myocardial injury after transaortic versus transapical transcatheter aortic valve replacement. Ann Thorac Surg2015; 99: 2001–2009.
44.
HarloffMTChowdhuryMHirjiSA, et al.A step-by-step guide to transseptal valve-in-valve transcatheter mitral valve replacement. Ann Cardiothorac Surg2021; 10: 104–121.
45.
StoneGWAdamsDHAbrahamWT, et al.Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the Mitral Valve Academic Research Consortium. Eur Heart J2015; 36: 1878–1891.
46.
EleidMFWhisenantBKCabalkaAK, et al.Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv2017; 10: 1932–1942.
47.
NeussMSchauTIsotaniA, et al.Elevated mitral valve pressure gradient after MitraClip implantation deteriorates long-term outcome in patients with severe mitral regurgitation and severe heart failure. JACC Cardiovasc Interv2017; 10: 931–939.
48.
KanekoTPiccirilloBGolwalaH, et al.Balloon fracture of a surgical mitral bioprosthesis during valve-in-valve transcatheter mitral valve replacement: first-in-human report. Circ Cardiovasc Interv2018; 11: e006273.
49.
BapatVVNKhalielFIhlebergL. Delayed migration of Sapien valve following a transcatheter mitral valve-in-valve implantation. Catheter Cardiovasc Interv2014; 83: E150–E154.
50.
SalaunEAldebertPJaussaudN, et al.Early endocarditis and delayed left ventricular pseudoaneurysm complicating a transapical transcatheter mitral valve-in-valve implantation: percutaneous closure under local anesthesia and echocardiographic guidance. Circ Cardiovasc Interv2016; 9: e003886.
51.
RegueiroALinkeALatibA, et al.Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. JAMA2016; 316: 1083–1092.
52.
El-SabawiBGuerreroMEEleidMF, et al.Hemolysis after transcatheter mitral valve replacement in degenerated bioprostheses, annuloplasty rings, and mitral annular calcification: incidence, patient characteristics, and clinical outcomes. Catheter Cardiovasc Interv. Epub ahead of print31 May 2021. DOI: 10.1002/ccd.29779.
53.
TamagniniGBourguignonTRegaF, et al.Device profile of the Inspiris Resilia valve for aortic valve replacement: overview of its safety and efficacy. Expert Rev Med Devices2021; 18: 239–244.
